Remove Connected Health Remove Interoperability Remove Meaningful Use Remove mHealth
article thumbnail

Who will regulate mHealth? Patient Engagement at Crossroads; New Alliance Takes On Interoperability

Chilmark Research

Public vs. Private Oversight of Mobile Health. mHealth, known for rapid innovation and iteration, has a tendency to buck at the snail’s pace of FDA regulation. This could herald a new age of credibility for mHealth. The group’s stated purpose is to enable interoperability across the five founding members’ EHRs.

mHealth 60
article thumbnail

Three Big Questions for Stage 3 & Patient Engagement

Chilmark Research

For many, the delay of Stage 3 of the Meaningful Use program evoked a collective sigh of relief, providing a much-needed extra year to focus on the challenging requirements for patient engagement and interoperability. How Will the Market Respond?